These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 1714641)
1. Hepatitis C virus infection in patients undergoing allogeneic bone marrow transplantation. Locasciulli A; Bacigalupo A; Vanlint MT; Tagger A; Uderzo C; Portmann B; Shulman HM; Alberti A Transplantation; 1991 Aug; 52(2):315-8. PubMed ID: 1714641 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus infection in thalassemia patients undergoing allogeneic bone marrow transplantation. Erer B; Angelucci E; Lucarelli G; Giardini C; Baronciani D; Galimberti M; Polchi P; Amadei G; Battistini L; Paolucci S Bone Marrow Transplant; 1994 Sep; 14(3):369-72. PubMed ID: 7527690 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus infection and liver disease after allogeneic bone marrow transplantation. Fujii Y; Kaku K; Tanaka M; Kaneko T; Matumoto N; Shinohara K Bone Marrow Transplant; 1994 May; 13(5):523-6. PubMed ID: 7519934 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus infection and allogeneic bone marrow transplantation. Norol F; Roche B; Girardin MF; Kuentz M; Desforges L; Cordonnier C; Duedari N; Vernant JP Transplantation; 1994 Feb; 57(3):393-7. PubMed ID: 7509088 [TBL] [Abstract][Full Text] [Related]
5. The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group. Locasciulli A; Testa M; Valsecchi MG; Bacigalupo A; Solinas S; Tomas JF; Ljungman P; Alberti A Transplantation; 1999 Nov; 68(10):1486-91. PubMed ID: 10589944 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation. Frickhofen N; Wiesneth M; Jainta C; Hertenstein B; Heymer B; Bianchi L; Dienes HP; Koerner K; Bunjes D; Arnold R Blood; 1994 Apr; 83(7):1998-2004. PubMed ID: 7511444 [TBL] [Abstract][Full Text] [Related]
7. Antibody response to hepatitis C virus infection after liver transplantation. Hsu HH; Wright TL; Tsao SC; Combs C; Donets M; Feinstone SM; Greenberg HB Am J Gastroenterol; 1994 Aug; 89(8):1169-74. PubMed ID: 7519818 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus genotypes and liver disease in patients undergoing allogeneic bone marrow transplantation. Locasciulli A; Testa M; Pontisso P; Bacigalupo A; Ljungman P; Frickhofen N; Alberti A Bone Marrow Transplant; 1997 Feb; 19(3):237-40. PubMed ID: 9028552 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection and liver failure in patients undergoing allogeneic bone marrow transplantation. Locasciulli A; Bacigalupo A; VanLint MT; Cavalletto D; Pontisso P; Testa M; Masera G; Shulman HM; Portmann B; Alberti A Bone Marrow Transplant; 1995 Sep; 16(3):407-11. PubMed ID: 8535314 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis C infection in BMT patients. Kolho E; Ruutu P; Ruutu T Bone Marrow Transplant; 1993 Feb; 11(2):119-23. PubMed ID: 7679597 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C seroprevalence in bone marrow transplant recipients and haemophiliacs. Jackson SR; Carter JM; Jackson TW; Green GJ; Hawkins TE; Romeril K N Z Med J; 1994 Jan; 107(970):10-1. PubMed ID: 7507581 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of anti-HCV in cryptogenic cirrhosis in a suburban Detroit community. Barnes RE; Meyer RA; Gordon SC Am J Gastroenterol; 1992 Aug; 87(8):1001-4. PubMed ID: 1379412 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up. Strasser SI; Myerson D; Spurgeon CL; Sullivan KM; Storer B; Schoch HG; Kim S; Flowers ME; McDonald GB Hepatology; 1999 Jun; 29(6):1893-9. PubMed ID: 10347135 [TBL] [Abstract][Full Text] [Related]
14. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology. Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391 [TBL] [Abstract][Full Text] [Related]
15. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Huang CC; Liaw YF; Lai MK; Chu SH; Chuang CK; Huang JY Transplantation; 1992 Apr; 53(4):763-5. PubMed ID: 1373534 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C in patients undergoing liver transplantation. Read AE; Donegan E; Lake J; Ferrell L; Galbraith C; Kuramoto IK; Zeldis JB; Ascher NL; Roberts J; Wright TL Ann Intern Med; 1991 Feb; 114(4):282-4. PubMed ID: 1846278 [TBL] [Abstract][Full Text] [Related]
17. Familial clustering of hepatitis C virus infection and chronic liver disease. Caporaso N; Morisco F; Romano M; Zembrino A; Coltorti M Ital J Gastroenterol; 1990 Oct; 22(5):281-2. PubMed ID: 1966878 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of antibodies to hepatitis C virus among family members of patients with chronic hepatitis C. Napoli N; Fiore G; Vella F; Fera G; Schiraldi O Eur J Epidemiol; 1993 Nov; 9(6):629-32. PubMed ID: 7512051 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of antibodies to hepatitis C virus in patients receiving renal replacement therapy, and in the staff caring for them. Blackmore TK; Stace NH; Maddocks P; Hatfield P Aust N Z J Med; 1992 Aug; 22(4):353-7. PubMed ID: 1280095 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection in liver allograft recipients. Caccamo L; Colledan M; Gridelli B; Rossi G; Doglia M; Gatti S; Ghidoni P; Lucianetti A; Lunghi G; Maggi U Arch Virol Suppl; 1993; 8():291-304. PubMed ID: 7505145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]